Pharmacists may administer epinephrine with an epinephrine delivery system, but only under this section’s rules.
Sec. 562.057. ADMINISTRATION OF EPINEPHRINE. (a) A pharmacist may administer epinephrine through an epinephrine delivery system in accordance with this section. (b) The board shall adopt rules designed to protect the public health and safety to implement this section. The rules must provide that a pharmacist may administer epinephrine through an epinephrine delivery system to a patient in an emergency situation. (c) A pharmacist may maintain, administer, and dispose of epinephrine delivery systems only in accordance with rules adopted by the board under this section. (d) A pharmacist who administers epinephrine through an epinephrine delivery system to a patient shall report the use to the patient's primary care physician, as identified by the patient, if the patient has a primary care physician. (e) A pharmacist who in good faith administers epinephrine through an epinephrine delivery system in accordance with the requirements of this section is not liable for civil damages for an act performed in the administration unless the act is wilfully or wantonly negligent. A pharmacist may not receive remuneration for the administration of epinephrine through an epinephrine delivery system but may seek reimbursement for the cost of the epinephrine delivery system. (f) The administration of epinephrine through an epinephrine delivery system to a patient in accordance with the requirements of this section does not constitute the unlawful practice of any health care profession. (g) In this section: (1) "Epinephrine auto-injector" means a disposable medical drug delivery device that contains a premeasured single dose of epinephrine intended for use to treat anaphylaxis. (2) "Epinephrine delivery system" means a medical delivery device approved by the United States Food and Drug Administration that delivers a dose of epinephrine intended for use to treat anaphylaxis, including: (A) an epinephrine auto-injector; and (B) an epinephrine nasal spray. Added by Acts 2015, 84th Leg., R.S., Ch. 1253 (H.B. 1550), Sec. 1, eff. January 1, 2016. Amended by: Acts 2025, 89th Leg., R.S., Ch. 67 (S.B. 1619), Sec. 29, eff. May 19, 2025. SUBCHAPTER C. PRACTICE BY PHARMACY